Medidata Debuts Protocol Optimization at ASCO, Leveraging AI to Transform the Study Experience

Core Insights - Medidata has launched Medidata Protocol Optimization, a new solution aimed at improving clinical trial design and execution, which will be showcased at the ASCO 2025 conference [1][3] - The solution utilizes AI-driven predictive modeling and digital protocols to enhance trial performance, reduce patient and site burden, and lower costs associated with clinical trials [2] Company Overview - Medidata is a leading provider of clinical trial solutions, celebrating 25 years of innovation with over 36,000 trials and 11 million patients involved [4] - The company offers a comprehensive platform that supports more than 1 million registered users across approximately 2,300 customers, focusing on improving patient experiences and accelerating clinical breakthroughs [4] Industry Context - Oncology trials are noted for their complexity, often requiring more adjustments than other therapeutic areas, highlighting the need for solutions like Protocol Optimization to streamline processes [3]